Global Personalized Medicine Market Is Expected to Reach $869.5 Billion by 2031: Says AMR
April 05, 2023 10:30 ET
|
Allied Market Research
Portland, OR, April 05, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Personalized Medicine Market was valued at $300.0 billion in 2021, and is...
OpGen’s Subsidiary Curetis Signs Expansion of R&D Collaboration with FIND
April 05, 2023 07:30 ET
|
OpGen, Inc.
Parties add several deliverables to initial R&D collaboration contractOverall potential revenue increased to up to euro 830 thousand ROCKVILLE, Md., April 05, 2023 (GLOBE NEWSWIRE) -- OpGen,...
OpGen’s Subsidiary Curetis Meets Milestones in Collaborative Research Project with InfectoGnostics
April 03, 2023 07:30 ET
|
OpGen, Inc.
PREPLEX project is part of broader InfectoGnostics Research Campus in Jena, GermanyTotal project volume of PREPLEX collaborative research is approximately $ 0.9 Mio ROCKVILLE, Md., April 03, 2023 ...
bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test
March 27, 2023 08:00 ET
|
bioLytical Laboratories Inc.
bioLytical has received Health Canada authorization to sell its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test across Canada for professional use in point-of-care settingsBy providing results for two...
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2022 on March 29th at 4:30 p.m. Eastern Time
March 22, 2023 07:30 ET
|
OpGen, Inc.
ROCKVILLE, Md., March 22, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its fourth quarter...
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023 16:05 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Bolyn Hubby, Ph.D., Executive Vice President and Chief Corporate Affairs Officer, will...
PDS Biotech Announces Publication of Preclinical Infectimune™ Based Vaccine Studies Demonstrating Effective Protection Against Viral Infection in Peer-Reviewed Journal, Viruses
February 08, 2023 16:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Feb. 08, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Artificial Intelligence in Drug Discovery Market Size & Share to Surpass $4197.5 Million by 2028 | Vantage Market Research
February 02, 2023 06:18 ET
|
Vantage Market Research
WASHINGTON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to the report published by Vantage Market Research, the Global Artificial Intelligence (AI) in Drug Discovery Market garnered $ 627.1 Million...
Veru Announces Appointment of Dr. David D. Ho as Chairman of its Infectious Disease Scientific Advisory Board
January 10, 2023 08:30 ET
|
Veru Inc.
MIAMI. FL, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for...
BioNTech kündigt Übernahme von InstaDeep an, um Vorreiterrolle auf dem Gebiet KI-basierter Arzneimittelforschung, -design und -entwicklung zu stärken
January 10, 2023 07:15 ET
|
BioNTech SE
Geplante Übernahme ermöglicht den Aufbau vollständig integrierter, unternehmensweiter Kapazitäten zur Erforschung, Konzeption und Entwicklung von Immuntherapien der nächsten Generation im großen...